Kang, Y., Yoo, C., Ryoo, B., Lee, J. J., Tan, E., Park, I., . . . Ryu, M. (2013). Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib. Nature Publishing Group.
Styl cytowania ChicagoKang, Y-K, et al. Phase II Study of Dovitinib in Patients With Metastatic And/or Unresectable Gastrointestinal Stromal Tumours After Failure of Imatinib and Sunitinib. Nature Publishing Group, 2013.
Styl cytowania MLAKang, Y-K, et al. Phase II Study of Dovitinib in Patients With Metastatic And/or Unresectable Gastrointestinal Stromal Tumours After Failure of Imatinib and Sunitinib. Nature Publishing Group, 2013.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..